supertramp: "One just has to wait. 3c looks expensive now when you look at the chart, but the market cap is far too low."
FULLY agree with you supertramp! Market cap is ridiculously LOW for what IMU has in their pipelines (not being a 'one-trick pony'!). As I mentioned times before, this has also to do with the fact that Australian investors do not seem to value biotech stocks like US investors do, i.e. IF IMU would be trading in the USA, it would be about double the current share-price (my estimate and purely JIMHO, of course).
As supertramp mentions: "One just has to wait". Patience should be well rewarded here. Once again: JIMHO, of course.
All the best to all IMU holders/buyers.
wasa
Add to My Watchlist
What is My Watchlist?
